TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer
Clinical trial NCT05190575 · COMPLETED
Trial details
- NCT number
- NCT05190575
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-14
- Primary completion
- 2023-05-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.